SOPHiA GENETICS to Announce Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022

Rhea-AI Summary

SOPHiA GENETICS (Nasdaq: SOPH) will announce its fourth quarter and full year 2021 financial results on March 15, 2022, prior to U.S. market opening. A conference call and webcast discussing these results and future outlook will take place at 8:30 a.m. ET. The company specializes in data-driven medicine, utilizing its SOPHiA DDM™ Platform to analyze multimodal data sets. The platform is deployed by approximately 790 healthcare institutions worldwide, reinforcing SOPHiA's position in the healthcare technology sector.

Positive

• SOPHiA's platform is in use by around 790 global healthcare institutions.
• Focus on establishing data-driven medicine as a standard of care.

Negative

• None.

BOSTON and LAUSANNE, Switzerland, Feb. 16, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the fourth quarter and full year 2021 before U.S. markets open on Tuesday, March 15, 2022. SOPHiA will host a conference call and live webcast to discuss its financial results as well as business outlook beginning at 8:30 a.m. Eastern Time / 2:30 p.m. Central European Time.

The call will be webcast live on the SOPHiA Investor Relations website. Additionally, an audio replay of the conference call and webcast will be available on the website after its completion.

About SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by approximately 790 hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM, or connect on Twitter, LinkedIn and Instagram. Where others see data, we see answers.

Investor Contact:
Jennifer Pottage
Head of Investor Relations
Jpottage@sophiagenetics.com

Media Contact:
Eliza Bamonti
Director of Public Relations
Ebamonti@sophiagenetics.com

FAQ

When will SOPHiA GENETICS release its financial results?

SOPHiA GENETICS will release its financial results for Q4 and full year 2021 on March 15, 2022.

What is the significance of SOPHiA GENETICS conference call?

The conference call will discuss the financial results and future business outlook, providing insights for investors.

How does SOPHiA GENETICS utilize its SOPHiA DDM™ Platform?

The SOPHiA DDM™ Platform analyzes multimodal data sets to enhance data-driven medicine practices.

What time is the SOPHiA GENETICS earnings call?

The earnings call is scheduled for 8:30 a.m. Eastern Time on March 15, 2022.

Where can I access the SOPHiA GENETICS earnings call webcast?

The earnings call will be available live on the SOPHiA Investor Relations website.